What is the primary goal of MAT for opioid dependency?

The primary goal of Medication-Assisted Treatment (MAT) for opioid dependency is indeed to reduce illicit opioid use and the associated risk of overdose. MAT combines the use of medications, such as methadone or buprenorphine, with counseling and behavioral therapies to provide a comprehensive approach to treating opioid use disorder.

This goal focuses on stabilizing the individual’s condition and facilitating recovery, making it less likely for individuals to engage in unsafe behaviors that lead to overdose or other health risks. By reducing the use of illicit opioids, MAT not only helps to improve the overall health outcomes for individuals but also contributes to the safety of the community by lowering the rates of drug-related incidents and deaths.

The other options do not align with the core objectives of MAT. Eliminating the need for medication might overlook the benefits of medication as a tool for recovery. Increasing the amount of opioids prescribed contradicts the principles of responsible prescribing and harm reduction. Ensuring lifelong dependence on medication can misrepresent the goal of MAT, which is to support individuals in their recovery journey, potentially leading to periods where medication can be reduced or eliminated as they gain stability and coping skills.